Molecular chaperones are well known as facilitators of protein folding and assembly. However, in recent years multiple chaperone-assisted degradation pathways have also emerged, including CAP ( haperone-ssisted roteasomal degradac a p tion), CASA ( haperone-ssisted elective utophagy), and c a s a CMA ( haperone-ediated utophagy). Within these pathc m a ways chaperones facilitate the sorting of non-native proteins to the proteasome and the lysosomal compartment for disposal. Impairment of these pathways contributes to the development of cancer, myopathies, and neurodegenerative diseases. Chaperone-assisted degradation thus represents an essential aspect of cellular proteostasis, and its pharmacological modulation holds the promise to ameliorate some of the most devastating diseases of our time. Here, we discuss recent insights into molecular mechanisms underlying chaperone-assisted degradation in mammalian cells and highlight its biomedical relevance.
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Introduction: chaperone-assisted degradation is essential for proteostasis
The proteome of living cells is highly dynamic. Proteins are constantly synthesized; they traffic through the cellular interior, adopt their functional conformation, and are ultimately turned over. Maintaining the proteome is a major challenge, considering that proteins must fold and function in the crowded environment of a cell that is exposed to physical, metabolic and environmental stresses. Cells have therefore evolved an intricate network of components that ensure protein homeostasis (proteostasis) (Powers et al., 2009 ). This proteostasis network balances the folding, misfolding, aggregation, and degradation of proteins in an adjustable manner. It adapts to alterations of the inherited proteome (e.g., mutations that make proteins more prone to misfolding or that disrupt parts of the proteostasis network itself), to physiological stimuli (such as growth factor and hormone signaling), and to environmental insults (such as heat or oxidative stress). Molecular chaperones are central players in this proteostasis network, because of their ability to bind non-native proteins following translation and stress-induced damage or during conformational regulation (Hartl and Hayer-Hartl, 2009 ). Chaperone function has been traditionally linked to the folding and assembly of proteins (Bukau and Horwich, 1998; Frydman, 2001; Young et al., 2004) . Accordingly, balancing folding and degradation in the context of proteostasis is often considered to rely on a competition of chaperonebased folding machineries with degradation systems, e.g., the ubiquitin/proteasome system and the autophagy/lysosome pathway ( Figure 1 , upper panel) (Marques et al., 2006; Powers et al., 2009) . Over the past decade it has become increasingly clear, however, that many chaperones, including members of the Hsp70 and Hsp90 chaperone families and small heat shock proteins, participate very actively in protein degradation. By interacting with components of the degradation systems, these chaperones were shown to facilitate the disposal of non-native proteins through proteasomal and autophagic degradation Arndt et al., 2007 Arndt et al., , 2010 Carra et al., 2008; Gamerdinger et al., 2009) .
Moreover, recent studies demonstrate that an impairment of chaperone-assisted degradation causes diverse diseases and age-related pathologies (Zhang and Cuervo, 2008; Kajiro et al., 2009; Selcen et al., 2009) . The 'degrading' activity of certain chaperones apparently fulfills an essential function within the proteostasis network. Chaperones should therefore no longer be viewed solely as protein folding factors, but rather as surveillance factors that constantly scan the cellular interior for the existence of non-native proteins. Upon recognition, chaperones prevent aggregation and are subsequently able to facilitate folding as well as degradation. We only begin to understand what determines the mode of action of a chaperone at this stage. The intrinsic properties of the chaperone client are certainly critical determinants, as degradation should proceed when the client is unable to attain a native conformation. The association of the chaperone with a defined set of regulatory co-chaperones appears to be important, too, because this results in the formation of a 'folding' or a 'degrading' chaperone complex (Figure 1 , lower panel). Possibly, the inability of a folding-incompetent client to escape chaperone recognition increases the likelihood of encountering a 'degrading' chaperone complex. In the following sections, we will discuss how diverse co-chap- Figure 1 Schematic presentation of how molecular chaperones and degradation systems operate during proteostasis. Traditionally, balancing protein folding and degradation was attributed to a competition between chaperones and components of the degradation machineries (e.g., the ubiquitin/proteasome system and the autophagy/lysosome pathway) (upper panel). The emerging novel concept assigns a more central role to molecular chaperones as cellular surveillance factors. They would initially bind a non-native client protein to prevent aggregation and would subsequently facilitate folding or degradation, dependent on an association with specialized co-chaperones that give rise to a folding or a degrading chaperone complex. 'prot. ', proteasome. erones help to establish specific degradation pathways in the cytoplasm of higher eukaryotes.
Multiple paths to destruction
Based on the underlying mechanisms three main pathways of chaperone-assisted degradation can be distinguished in the cytoplasm of higher eukaryotes. haperone-ssisted rotea-C a p somal degradation (called CAP hereafter) involves the ubiquitylation of a chaperone client and its subsequent sorting to the proteasome (Arndt et al., 2007) . haperone-ssisted C a elective utophagy (called CASA hereafter) refers to the s a engulfment of a ubiquitylated chaperone client by an autophagic isolation membrane leading to lysosomal degradation (Carra et al., 2008; Gamerdinger et al., 2009; Kirkin et al., 2009b; Arndt et al., 2010) . Finally, haperone-ediated utoc m a phagy (CMA) relies on the ubiquitin-independent chaperoneassisted transport of a client molecule directly across the lysosomal membrane .
CAP: chaperone-assisted proteasomal degradation
Of central importance for CAP is the co-chaperone and ubiquitin ligase CHIP that binds constitutively expressed Hsc70, stress inducible Hsp70, and Hsp90, to initiate client sorting to the proteasome (Arndt et al., 2007) . CHIP was shown to be involved in the degradation of a broad range of chaperone clients, including signaling proteins and apoptosis regulators, which associate with Hsc/Hsp70 and Hsp90 during their conformational regulation (e.g., Raf-1, ErbB2, steroid hormone receptors, p53). A second subgroup of clients includes aggregation-prone proteins that are recognized by the chaperones during protein quality control and are therefore amenable to CHIP-induced degradation (e.g., mutant CFTR, hyperphosphorylated Tau, mutant SOD-1; reviewed in Arndt et al., 2007) . The client repertoire illustrates the large biomedical relevance of CAP with regard to cancer and protein misfolding diseases such as cystic fibrosis, Alzheimer's disease, and amyotrophic lateral sclerosis. In fact, a recent study identifies CHIP as an upstream regulator of multiple oncogenic pathways in human breast cancer tissues, with the expression of CHIP being negatively correlated with tumor malignancy (Kajiro et al., 2009 ). The transcriptional co-activator SRC-3 is a direct target of CAP in this context. If CHIP levels are low, SRC-3 levels increase, which drives tumor growth and invasiveness through an elevated expression of oncogenic and antiapoptotic proteins, including Bcl-2, Akt1, Smad, and Twist (Kajiro et al., 2009 ). Another interesting recent study demonstrates that CHIP induces the degradation of the cell growth and proliferation regulator Raf-1 in a manner facilitated by inhibitor of apoptosis proteins (Dogan et al., 2008) . Furthermore, Parsons and coworkers showed that CHIP participates in the proteasomal degradation of base excision repair proteins, that are frequently overexpressed in cancer cells (Parsons et al., 2008) . Taken together, these studies highlight that CAP acts at multiple stages to control oncogenic transformation, making the chaperone-assisted degradation pathway a promising target for therapeutic intervention in cancer. Indeed, modulating CAP activity through inhibition of Hsp90 is currently explored in clinical trials as an anti-cancer treatment (Barginear et al., 2008; Koga et al., 2009 ). In the presence of Hsp90 inhibitors client processing is blocked at an Hsc/Hsp70-bound stage, leading to an accelerated degradation through CAP.
CHIP-mediated CAP was also linked to the degradation of diverse proteins that accumulate as pathological aggregates in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (reviewed in Arndt et al., 2007) . One of these CAP substrates is the microtubule binding protein tau that forms neurofibrillary tangles in Alzheimer patients and other tauopathies following its hyperphosphorylation (Brandt and Leschik, 2004) . Hyperphosphorylated tau is a client of the Hsc/Hsp70 and Hsp90 chaperone network and is targeted for proteasomal degradation by CHIP (Shimura et al., 2004; Dickey et al., 2007 ). An Hsp90 inhibitor that is able to cross the blood-brain barrier (e.g., EC102) induces tau degradation through CHIP-mediated CAP in cellbased assays and facilitates the disposal of aberrant tau in a transgenic mouse model of tauopathy (Dickey et al., 2007) . 
Figure 2
The association of the Hsc/Hsp70 chaperones with diverse co-chaperones determines their activity as facilitators of protein folding or protein degradation. During the initial recognition of a client protein Hsc/Hsp70 cooperates with J-domain co-chaperones that stimulate ATP hydrolysis by the chaperones. This leads to high affinity client binding through a closure of the carboxy-terminal domain of the chaperone ('C') over the peptide binding pocket ('P'). Upon association with HIP and HOP the chaperone mediates protein folding, whereby HOP provides a binding site for Hsp90 to facilitate chaperone interactions during client processing. Binding of the proteasome interactor BAG-1 and the chaperone-associated ubiquitin ligase CHIP, which compete with HIP and HOP for chaperone interaction, initiates chaperone-assisted proteasomal degradation (CAP) (prot., proteasome interacting ubiquitin-like domain of BAG-1). CHIP cooperates with its partner ubiquitin-conjugating enzymes Ubc4 and Ubc5 to mediate the attachment of a ubiquitin chain onto the chaperonebound client. Another co-chaperone that cooperates with CHIP during CAP is HSJ-1, which is able to bind ubiquitylated client proteins and to facilitate their sorting to the proteasome. By contrast, the ubiquitin ligase activity of CHIP is inhibited upon binding of HspBP1 or BAG-2 to the chaperone/CHIP complex. HspBP1 seems to block the access of CHIP to ubiquitin attachment sites, whereas BAG-2 prevents an interaction of CHIP with Ubc4/5. Chaperoneassisted selective autophagy (CASA) is initiated by BAG-3, which acts as a coupling factor between the oligomeric small heat shock protein HspB8 and Hsc/Hsp70 to facilitate the processing of large or bulky client proteins, such as the Z-disk protein filamin. Targeting to the lysosome involves CHIP-mediated ubiquitylation of the client and subsequent recognition by the ubiquitin adaptor p62 that interacts at the same time with the phagophore membrane. Engulfment of the ubiquitylated client leads to the formation of an autophagosome that eventually fuses with a lysosome, causing client degradation. In the case of chaperone-mediated autophagy (CMA) a single client molecule is directly transferred across the lysosomal membrane and degraded in the lumen, after an interaction of Hsc70 with the lysosomal membrane protein LAMP-2A and transient formation of a translocase. Lysosomal Hsc70 participates in the translocation. It is unclear whether CMA involves Hsc70 regulation by CMA-specific co-chaperones ('?').
Modulating CAP activity thus also emerges as a therapeutic strategy in neurodegenerative diseases.
The cell itself has multiple ways to regulate CHIPmediated CAP within the chaperone/co-chaperone network. Degradation is stimulated upon binding of BAG-1 and HSJ-1, respectively, to the chaperone/CHIP complex (Figure 2 ). BAG-1 facilitates the docking of the complex at the proteasome, because it possesses a ubiquitin-like domain integrated in its primary structure, which is used for proteasome binding (Demand et al., 2001; Alberti et al., 2002) . HSJ-1 belongs to the family of J-domain containing substrate-loading factors of Hsc/Hsp70 and in addition displays two ubiquitin interaction motifs that enable the co-chaperone to bind ubiquitylated chaperone clients after their initial encounter with CHIP (Westhoff et al., 2005 ; Figure 2 ). The combination of these activities allows HSJ-1 to facilitate the rebinding of ubiquitylated clients to Hsc/Hsp70 during sorting to the proteasome. In this way, the co-chaperone promotes the degradation of aggregation-prone forms of huntingtin in neuronal cells (Westhoff et al., 2005; Howarth et al., 2007) . Another J-protein recently shown to facilitate CHIP-mediated degradation is the cysteine string protein (CSP), which is abundantly expressed in neurons, where it localizes to presynaptic junctions (Schmidt et al., 2009 ). Deletion of the CSP gene proved to be lethal both in Drosophila and in mice causing a progressive, fatal sensorimotor disorder (Zinsmaier et al., 1994; Fernandez-Chacon et al., 2004) . CSP interacts directly with CHIP and facilitates interactions of CHIP with chaperone clients (Schmidt et al., 2009) .
By contrast, CHIP-mediated CAP can also be attenuated. Certain co-chaperones that promote folding pathways compete with CAP-stimulating co-chaperones. The Hsc70/Hsp90 coupling factor HOP, e.g., occupies the same binding sites on Hsc70 and Hsp90 as CHIP, and the Hsc/Hsp70 interacting protein HIP competes with BAG-1 in binding to the ATPase domain of Hsc/Hsp70 (Figure 2) (Connell et al., 2001 ). Yet other co-chaperones are able to associate with the chaperone/ CHIP complex and then modulate CHIP-mediated degradation in the formed ternary complex (Figure 2 ). Among these regulators are the Hsc/Hsp70 co-chaperones BAG-2 and HspBP1, which both act as degradation inhibitors (Alberti et al., 2004; Arndt et al., 2005; Dai et al., 2005) . They inhibit the ubiquitin ligase activity of CHIP in the formed chaperone/co-chaperone complex, and the resultant attenuation of CAP was shown to be important for the maturation of the cystic fibrosis ion channel CFTR (Alberti et al., 2004; Arndt et al., 2005) .
How the interplay between different co-chaperones influences the fate of a chaperone client was recently revealed in a study investigating the toxin ricin (Spooner et al., 2008) . After uptake into mammalian cells through endocytosis the toxin enters the endoplasmic reticulum from where it is retrotranslocated in the cytoplasm. Following retrotranslocation the toxin is recognized by the Hsc/Hsp70 and Hsp90 chaperone systems. Its eventual fate is then determined by the balanced activity of diverse co-chaperones, with CHIP and BAG-1 triggering degradation and BAG-2 exerting a stabilizing activity (Spooner et al., 2008) . In summary, it becomes obvious that the co-chaperone network plays a prominent role in balancing protein folding and degradation during proteostasis.
CHIP-deficient mice display a decreased life span and accelerated aging characterized by an accumulation of misfolded proteins at the cellular level (Min et al., 2008) . The co-chaperone is apparently a determining factor for life span in mammals. An age-dependent increase in protein oxidation and modification that exacerbates aggregation together with a general decline in quality control mechanisms could explain the phenotypic manifestation of CHIP deficiency in aged organisms. It remains to be determined, however, whether the observed phenotype is indeed caused by impaired CAP. CHIP fulfils a degradation-independent function in the heat shock response by regulating the interaction of the heat shock transcription factor HSF-1 with Hsp90 (Dai et al., 2003) . The lack of the co-chaperone could therefore broadly affect the ability of the organism to cope with protein misfolding. Notably, degradation of chaperone clients proceeds unaffected in CHIP-deficient cells treated with Hsp90 inhibitors (Xu et al., 2002) . This points to the existence of additional chaperone-associated ubiquitin ligases that exert functions overlapping with CHIP during CAP. Indeed, Cul5, a member of the cullin family of ubiquitin ligases, was very recently shown to associate with Hsc/Hsp70 and Hsp90 chaperone complexes and to trigger the proteasomal degradation of the chaperone clients ErbB2 and Hif-1a (Ehrlich et al., 2009 ). Another emerging candidate in this regard is the ubiquitin ligase parkin, mutations in which cause early onset forms of Parkinson's disease (Kitada et al., 1998) . Parkin is able to associate with Hsc/Hsp70 and displays a substrate specificity that partially overlaps with the one of CHIP (Imai et al., 2002; Tsai et al., 2003; Morishima et al., 2008) . Moreover, parkin activity is under control of the Hsc/Hsp70 co-chaperone BAG-5, which further emphasizes its function as a chaperone-associated ubiquitin ligase (Kalia et al., 2004) . In a recent publication, the ubiquitin ligase E6-AP was also shown to be associated with Hsc/Hsp70 and to participate in the ubiquitylation and degradation of chaperone clients (Mishra et al., 2009 ). The interaction of Hsp90 with SGT1, an interactor of the hetero oligomeric SCF ubiquitin ligase complex, points to yet another ubiquitin conjugation machinery that could potentially be involved in CAP (Kitagawa et al., 1999; Mayor et al., 2007; . Finally, the small heat shock protein a-B crystallin that is overexpressed in many neurological diseases was shown to associate with the SCF complex adaptor Fbx4 and to stimulate the Fbx4-mediated ubiquitylation of as yet to be identified substrate proteins (den Engelsman et al., 2003) . In summary, CAP apparently does not involve only one highly defined pathway but rather relies on different chaperones that team up with diverse chaperone-associated ubiquitin ligases and ancillary factors to direct chaperone clients towards the proteasome.
CASA: chaperone-assisted selective autophagy
In addition to the proteasome, the lysosomal compartment represents a major site for protein degradation (Rubinsztein, 2006; Eskelinen and Saftig, 2009 ). Cellular components are targeted to the lysosomal compartment in a process termed autophagy (Yorimitsu and Klionsky, 2005; Mizushima et al., 2008) . This can involve an engulfment of cytosolic material with a phagophore membrane to form an autophagosome capable of fusion with the lysosome (macroautophagy) or a direct sequestration of cytosol through an invagination of the lysosomal membrane (microautophagy). Although autophagy can degrade cytosolic material non-specifically, e.g., as a response to starvation, there is ample evidence for a selective autophagic degradation of various cellular structures, including protein aggregates, diverse organelles (e.g., mitochondria and peroxisomes), and microbes (Xie and Klionsky, 2007; Kirkin et al., 2009b) . Intriguingly, in some instances selective autophagy involves ubiquitylation as the initial degradation signal, comparable to proteasomal degradation. The ubiquitin signal is then recognized by the adaptor proteins p62 or NBR1 that are able to interact at the same time with the phagophore membrane and thereby initiate the selective engulfment of ubiquitylated proteins (Komatsu et al., 2007; Pankiv et al., 2007; Kirkin et al., 2009a) . Recent research now points to a participation of molecular chaperones in this process, which is triggered by a dedicated co-chaperone, namely BAG-3, giving rise to chaperone-assisted selective autophagy: CASA (Carra et al., 2008; Gamerdinger et al., 2009; Arndt et al., 2010;  Figure 2 ). BAG-3 is a co-chaperone of Hsc/Hsp70 and the small heat shock protein HspB8 (Carra et al., 2008; Gamerdinger et al., 2009; Arndt et al., 2010) . Remarkably, it facilitates an association of the autophagic ubiquitin adaptor p62 with the chaperone machinery and in this way directs diverse chaperone clients towards lysosomal degradation (Carra et al., 2008; Gamerdinger et al., 2009; Arndt et al., 2010) . Autophagic flux was shown to correlate with BAG-3 levels in different cell types, with siRNA-mediated depletion of the co-chaperone leading to a significant decrease of overall autophagic activity (Carra et al., 2008; Gamerdinger et al., 2009) . CASA apparently represents a main route for the lysosomal degradation of cellular components under normal growth conditions. Its relevance for proteostasis even seems to increase with age. Behl and coworkers demonstrated that BAG-3 levels are upregulated in aged neuronal cells, resulting in an increased targeting of oxidized and ubiquitylated proteins to the lysosome for disposal (Gamerdinger et al., 2009) . The induction of BAG-3 mediated CASA apparently represents an important adaptation of the protein quality control system of neuronal cells to maintain proteostasis in the presence of an enhanced prooxidant and aggregation-prone milieu characteristic of aging (Terman et al., 2007) .
Remarkably, mice deficient for BAG-3 develop a progressive muscle weakness leading to death shortly after birth (Homma et al., 2006) . In addition to aged neuronal cells, muscle cells apparently highly rely on CASA. This is further emphasized by the fact that a mutation in human BAG-3 (P209L) causes a rapidly progressing myopathy in affected children (Selcen et al., 2009) . How the observed pathologies relate to the regulatory role of BAG-3 in chaperone-assisted selective autophagy was recently elucidated (Arndt et al., 2010) . In muscle cells, BAG-3 and its chaperone partner HspB8 are specifically localized at the Z-disk, a multiprotein assembly that is required for the bundling and anchoring of actin filaments (Frank et al., 2006; Homma et al., 2006) . This localization enables BAG-3 to recruit Hsc/Hsp70 and CHIP to the Z-disk. The chaperone machinery then mediates the processing and ubiquitylation of Z-disk components that were damaged during muscle contraction to initiate their disposal through CASA (Arndt et al., 2010) . BAG-3 was found to be upregulated in contracting muscles (Arndt et al., 2010) , and impairment of BAG-3 activity in transgenic animals and patients resulted in a contraction-dependent disintegration of the Z-disk (Homma et al., 2006; Selcen et al., 2009 ). The Zdisk component filamin was identified as a critical substrate of CASA in muscle cells (Arndt et al., 2010) . Filamin is a 280 kDa protein that contains 24 immunoglobulin-like domains, which can undergo strain-and temperature-induced reversible unfolding, and two natively unstructured hinge regions (Schwaiger et al., 2004 (Schwaiger et al., , 2005 Popowicz et al., 2006; Jiang and Campbell, 2008; Kesner et al., 2009 ). This domain arrangement enables the protein to act as an extensible anchor between actin and membrane proteins such as integrins (Popowicz et al., 2006) . Intriguingly, a recently identified mutation in human filamin causes a progressive myopathy with Z-disk disruption, resembling the pathology of BAG-3 (P209L) patients (Vorgerd et al., 2005) . Continuous unfolding and refolding cycles seem to make filamin prone to irreversible damage in the contracting muscle, resulting in a necessity for chaperone-assisted disposal. The elucidation of BAG-3 function in muscle cells thus illustrates the importance of chaperone-assisted degradation for the preservation of cellular structures under non-pathological conditions.
CASA is an evolutionary conserved degradation pathway in muscles. The Drosophila BAG domain co-chaperone starvin is a functional ortholog of BAG-3. Similar to its mammalian counterpart it is concentrated at Z-disks and coordinates the formation of a multicomponent chaperone complex at this location, comprising Drosophila HspB8, Hsc70, and CHIP (Arndt et al., 2010) . Homozygous animals deficient for starvin die early during larval development because of impaired muscle activity. Notably, heterozygous flies are able to reach the adult stage but develop an agedependent muscle weakness (Arndt et al., 2010) . The CASAinducing co-chaperones are apparently conserved components of the proteostasis machinery in muscle cells, with reduced expression being sufficient to cause systemic failure.
The identification of CASA as an essential proteostasis mechanism in muscles has important implications for our understanding of diverse diseases and age-dependent pathologies. It is tempting to speculate, e.g., that the progressive muscle weakness frequently observed among elderly people might be caused at least in part by an age-dependent decline in the activity of the proteostasis machinery. Furthermore, deregulated autophagy was shown to contribute to the pathology of Pompe disease and was recognized as a primary cause of Danon disease, centronuclear myopathy, and Xlinked myopathy with excessive autophagy (Nishino et al., 2000; Tanaka et al., 2000; Malicdan et al., 2008; Raben et al., 2008; Ramachandran et al., 2009; Vergne et al., 2009) . The different diseases involve a progressively developing muscle weakness, which again illustrates the importance of autophagy for muscle maintenance. However, why the deregulation of a basic cellular process such as autophagy preferentially affects muscle activity remained elusive for a long time (Hirano and DiMauro, 2009) . The finding that the continuous autophagic degradation of damaged filamin at the Zdisk is a requirement for muscle maintenance now provides an answer to this question. Indeed, filamin accumulates in aggregates in mice deficient for LAMP-2, which recapitulate pathological hallmarks of Danon disease (Arndt et al., 2010) .
Proteasomal and autophagic degradation do not operate independently but are closely interconnected (Ding et al., 2007; Pandey et al., 2007; Korolchuk et al., 2009) . The chaperone-associated ubiquitin ligase CHIP apparently acts as a dual function ubiquitin ligase that can operate on autophagic as well as proteasomal degradation pathways (e.g., CASA and CAP, see above) (Arndt et al., 2007 (Arndt et al., , 2010 . In this situation, regulation by BAG domain co-chaperones could be of critical importance for pathway selection. The competitive interaction of the autophagy inducer BAG-3 and the proteasome interactor BAG-1 with the chaperone/CHIP complex can serve as a molecular switch between CASA and CAP. In support of this concept, the expression of the two BAG domain co-chaperones was found to be inversely altered during aging, with BAG-3 levels increasing and BAG-1 levels declining, causing a shift from proteasomal to autophagic degradation of polyubiquitylated proteins (Gamerdinger et al., 2009 ). Strikingly, siRNA-induced depletion of BAG-1 in cultured cells led to an upregulation of BAG-3, and, conversely, BAG-3 depletion provoked an increased expression of BAG-1 (Gamerdinger et al., 2009 ). The coordinated regulation of CAP and CASA could provide a means for compensatory responses when one degradation pathway is impaired or overwhelmed by substrate accumulation.
In addition to CHIP, parkin can also act as a dual function chaperone-associated ubiquitin ligase. Although initially linked to proteasomal degradation (Imai et al., 2002) , recent research shows that parkin is selectively recruited to dysfunctional mitochondria and triggers their disposal through selective autophagy (Narendra et al., 2008; Geisler et al., 2010) . Conceivably, parkin can cooperate with the Hsc/ Hsp70 chaperone system during the recognition of damaged mitochondria that can expose unfolded proteins at their surface. Although this hypothesis currently awaits experimental verification, CASA also seems to comprise multiple pathways.
CMA: chaperone-mediated autophagy
CMA is rather distinct from other autophagy pathways, because it does not involve vesicle formation or membrane invagination. Instead, a single client molecule is directly transferred across the lysosomal membrane to achieve degradation (Dice, 2007) . CMA clients contain a lysosomal targeting motif consisting of the pentapeptide KFERQ. This motif is present in approximately 30% of cytoplasmic proteins and is recognized directly by Hsc70 (Chiang and Dice, 1988; Chiang et al., 1989) . The chaperone/client complex subsequently docks at the lysosomal membrane through binding to the membrane protein LAMP-2A, one out of three isoforms encoded by the lamp-2 gene, and this seems to initiate the dynamic formation of a translocase within the membrane for client transfer (Cuervo and Dice, 1996; Kaushik et al., 2006; Bandyopadhyay et al., 2008;  Figure 2 ). Translocation appears to be facilitated by Hsc70 molecules that are present in the lysosomal lumen, although it is unclear how these molecules are sorted to this location (Agarraberes et al., 1997) .
It also remains to be analyzed how CMA is regulated at the stages that involve Hsc70 activity. In analogy to the findings for the regulation of CAP and CASA one might speculate about the involvement of specialized co-chaperones (see above). However, folding-as well as degradation-inducing co-chaperones were detected at the lysosomal membrane, including the Hsc70/Hsp90-coupling factor HOP and the proteasome docking factor BAG-1 (Agarraberes and Dice, 2001) . It therefore seems possible that binding of Hsc70 to LAMP-2A is itself the decisive step for directing a chaperone client onto the CMA pathway.
CMA is maximally activated during stresses such as prolonged starvation, mild oxidation, and other conditions that result in protein damage (Dice, 2007) . In fact, CMA seems to play a major role in the removal of oxidatively damaged proteins that are increasingly formed in aged cells (Kiffin et al., 2004) . Furthermore, in neuronal cells CMA mediates the degradation of a-synuclein, a main component of amyloid aggregates formed in Parkinson's disease . Pathogenic forms of a-synuclein still bind to LAMP-2A but are only poorly translocated into lysosomes. As a consequence, the degradation of other CMA clients is also decreased, putting additional strain on the proteostasis network in the pathological situation . It is also noteworthy in this context that CMA activity decreases with age (Cuervo and Dice, 2000) . This is apparently caused by an age-dependent decline in the levels of the CMA receptor LAMP-2A. Indeed, recombinant expression of LAMP-2A in the liver of aged transgenic mice restored CMA activity, reduced the accumulation of oxidatively damaged proteins, and improved organ function (Zhang and Cuervo, 2008) . With the recent emergence of CASA, it will be interesting to evaluate, however, whether altered LAMP-2A levels not only affect CMA but also CASA. In any case, a decreased ability of cells to remove damage proteins via CMA appears to contribute significantly to the pathology of certain amyloid diseases and could be a major cause of the systemic breakdown of proteostasis in aged organisms.
Concluding remarks
Exciting work of many laboratories in the past couple of years has clearly established the importance of chaperoneassisted degradation for proteostasis. Non-dividing neuronal and muscle cells are unable to survive without an ability to remove misfolded proteins through CAP, CASA, or CMA. An impairment of chaperone-assisted degradation contributes to the development of cancer, myopathies, and neurodegenerative diseases, and is now recognized as a major hallmark of aging at the cellular level. Our increasing knowledge about co-chaperones that regulate chaperone-assisted degradation could open unique opportunities for therapeutic intervention. It is about time that 'degrading' chaperones enter textbooks of cell biology and biomedicine.
